Sarepta

sarepta building
Favicon Fierce Pharma

FDA backtracks on Sarepta's gene therapy Elevidys in DMD

The agency said that it had concluded that the death of an 8-year-old was not related to Elevidys but addressed none of the three prior deaths.
Angus Liu Jul 28, 2025 6:02pm
timer sand clocks time

Arrowhead meets $100M milestone, awaits Sarepta payment

Jul 28, 2025 3:10pm
FDA
Favicon Fierce Pharma

FDA eyeing study requirements to confirm Elevidys safety: report

Jul 24, 2025 3:12pm
An artists impression of DNA The DNA appears to be made up of glowing orbs and appears on a blue background

FDA slaps clinical hold across all of Sarepta’s LGMD trials

Jul 21, 2025 11:36am
Sarepta Sarepta Therapeutics
Favicon Fierce Pharma

Sarepta will continue shipping Elevidys despite FDA misgivings

Jul 21, 2025 10:42am
Redbrick building with Sarepta name and logo
Favicon Fierce Pharma

FDA contemplates pulling Sarepta’s Elevidys from market

Jul 18, 2025 3:10pm